Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole
Europace · 2023
DOI: 10.1093/europace/euad061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Gerhard Hindricks und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Heart Centre Leipzig and Leipzig Heart Institute, Strümpellstrasse 39, 04289 Leipzig, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Defibrillators, Implantable, Stroke. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Biotronik.
Abstract (Originalsprache)
Aims
To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs) and progression of arrhythmia duration along pre-specified strata (6 min…<1 h, 1 h…<24 h, ≥ 24 h). We used the MATRIX registry data to assess the capability of a single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (DX ICD system) to follow this recommendation in patients with standard indication for single-chamber ICD. Methods and results In 1841 DX ICD patients with daily automatic RM transmissions, electrograms of first device-detected AHREs per patient in each duration stratum were adjudicated, and the corresponding positive predictive values (PPVs) for the detections to be true atrial arrhythmia were calculated. Moreover, the incidence and progression of new-onset AF was assessed in 1451 patients with no AF history. A total of 610 AHREs ≥6 min were adjudicated. The PPV was 95.1% (271 of 285) for episodes 6min…<1 h, 99.6% (253/254) for episodes 1 h…<24 h, 100% (71/71) for episodes ≥24 h, or 97.5% for all episodes (595/610). The incidence of new-onset AF was 8.2% (119/1451), and in 31.1% of them (37/119), new-onset AF progressed to a higher duration stratum. Nearly 80% of new-onset AF patients had high CHA2DS2-VASc stroke risk, and 70% were not on anticoagulation therapy. Age was the only significant predictor of new-onset AF.
Conclusion
A 99.7% detection accuracy for AHRE ≥1 h in patients with DX ICD systems in combination with daily RM allows a reliable guideline-recommended screening for subclinical AF and monitoring of AF-duration progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electrophysiology, Heart Centre Leipzig and Leipzig Heart Institute, Strümpellstrasse 39, 04289 Leipzig, Germany.
- Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 GD Rotterdam, The Netherlands.
- Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel.
- Arrhythmia Unit, Heart Diseases Institute, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, Feixa Llarga, 08907 L'Hospitalet, Barcelona, Spain.
- Sherbrooke University Hospitals (CHUS), 3001 12e Avenue Nord, J1H 5N4 Sherbrooke, Quebec, Canada.
- Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany.
ORCID-Profile: Gerhard Hindricks, Dominic A Theuns, David Bar-Lev, Ignasi Anguera, Félix Alejandro Ayala Paredes, Katia Marjolaine Dyrda, Giampiero Maglia, Sylvain Ploux, Carina Blomström-Lundqvist, Yanchun Liang, Igor Diemberger, Jerzy Krzysztof Wranicz, Fabio Quartieri, Tobias Timmel, Andreas Bollmann
Förderung
- Biotronik
Zitieren
APA
Hindricks, G., Theuns, D. A., Bar-Lev, D., Anguera, I., Ayala Paredes, F. A., Arnold, M., Geller, J. C., Merkely, B., Dyrda, K. M., Perings, C., Maglia, G., Ploux, S., Meyhöfer, J., Blomström-Lundqvist, C., Karjalainen, P., Liang, Y., Diemberger, I., Wranicz, J. K., Barr, C., …, & Bollmann, A. (2023). Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole. Europace. https://doi.org/10.1093/europace/euad061
Vancouver
Hindricks G, Theuns DA, Bar-Lev D, Anguera I, Ayala Paredes FA, Arnold M, et al. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole. Europace. 2023. doi:10.1093/europace/euad061
BibTeX
@article{Hindricks2023,
author = {Hindricks, Gerhard and Theuns, Dominic A and Bar-Lev, David and Anguera, Ignasi and Ayala Paredes, Félix Alejandro and Arnold, Martin and Geller, J Christoph and Merkely, Béla and Dyrda, Katia Marjolaine and Perings, Christian and Maglia, Giampiero and Ploux, Sylvain and Meyhöfer, Jürgen and Blomström-Lundqvist, Carina and Karjalainen, Pasi and Liang, Yanchun and Diemberger, Igor and Wranicz, Jerzy Krzysztof and Barr, Craig and Quartieri, Fabio and Timmel, Tobias and Bollmann, Andreas},
title = {Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad061}
}
EUVIMED